MetLife director granted 587 deferred stock shares

MetLife Inc. director Jeh C. Johnson reported an acquisition of 587 shares of MetLife common stock on June 16, 2026 as a grant or award.

Rhea-AI Filing Summary

MetLife Inc. director Jeh C. Johnson reported an acquisition of 587 shares of MetLife common stock on June 16, 2026 as a grant or award. These shares represent a portion of his non-management director retainer that is paid in stock and deferred under the MetLife Deferred Compensation Plan for Non-Management Directors. Following this grant, he directly holds 9,498 shares.

Insider Trade Summary

Grant/Award: 587 shares

Grant/Award 1 txn

Insider Johnson Jeh C.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	587	$87.40	$51K

Holdings After Transaction: Common Stock — 9,498 shares (Direct)

Footnotes (1)

1. F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Key Figures

Shares granted: 587 shares Grant price: $87.40 per share Total holdings after grant: 9,498 shares +2 more

5 metrics

Shares granted 587 shares Common Stock grant on June 16, 2026

Grant price $87.40 per share Value used for stock award

Total holdings after grant 9,498 shares Direct MetLife common stock held after transaction

Transaction code A Grant, award, or other acquisition of non-derivative common stock

Transaction direction acquire Compensation-related stock award, not an open-market purchase

Key Terms

Deferred Compensation Plan for Non-Management Directors, retainer fees, Common Stock, Grant, award, or other acquisition

4 terms

Deferred Compensation Plan for Non-Management Directors financial

"deferred receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors"

retainer fees financial

"non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock"

Common Stock financial

"MetLife, Inc. common stock. The director elected to defer receipt of these shares"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction code description shows "Grant, award, or other acquisition" for the common stock entry"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MetLife (MET) director Jeh C. Johnson report?

Jeh C. Johnson reported receiving 587 shares of MetLife common stock as a grant or award. The shares represent part of his director retainer, which is paid in stock and deferred under MetLife’s Deferred Compensation Plan for Non-Management Directors.

Was Jeh C. Johnson’s MetLife Form 4 transaction a market purchase or compensation grant?

The Form 4 shows a compensation-related grant, not a market purchase. Code "A" and the footnote explain that a portion of non-management director retainer fees is paid in MetLife common stock and deferred under the company’s Deferred Compensation Plan.

How many MetLife shares does Jeh C. Johnson hold after this reported grant?

After the reported grant, Jeh C. Johnson directly holds 9,498 shares of MetLife common stock. This total reflects the addition of 587 shares received as part of his non-management director retainer compensation arrangement paid in stock and deferred under the specified plan.

At what price per share was Jeh C. Johnson’s MetLife stock grant reported?

The grant was reported at a price of $87.40 per share for 587 MetLife common shares. This price reflects the value used for the compensation entry and does not indicate an open-market trade, as the shares were awarded under director compensation arrangements.

How is MetLife compensating non-management directors according to this Form 4?

MetLife compensates non-management directors by paying a portion of their retainer fees in MetLife common stock. The footnote states that the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors, turning cash-equivalent fees into deferred stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:12 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Jeh C.

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A(1)		587	A	$87.4	9,498	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)